Dalir Joins National Effort To Enable 3D Optical Packaging for Next-Gen AI Chips
UF researcher Hamed Dalir, Ph.D., is collaborating on a $5.2 million federally funded project to develop a transformative 3D optical packaging platform that enables scalable, high-bandwidth, energy-efficient chip-to-chip optical communication.
XPRIZE UF
UF Innovate | The Hub resident client FNN, in collaboration with UF researchers, advances to the semi-finals of the XPRIZE Wildfire competition with its AI-driven technology aimed at early detection and suppression of wildfires.
UF Scientists Join European Effort To Develop Antiviral Drugs for Future Pandemics
UF researchers have joined a European research network that aims to develop broad-spectrum antiviral drugs to combat the next global pandemic.
The Conversation: Researchers Uncovered Hundreds of Genes Linked to OCD, Providing Clues About How It Changes the Brain
UF researchers Carol Mathews contribute to a groundbreaking international study uncovering genetic factors linked to Obsessive-Compulsive Disorder, paving the way for enhanced understanding and treatment of the condition.
Seeding Exploration
UF researchers Rob Ferl and Anna-Lisa Paul are advancing space agriculture by successfully growing plants in lunar soil, a breakthrough that supports the future of human space exploration.
Tech Tuesday: University of Florida Startup Aims To Improve How Polymers Are Made
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey interviews Gregory Kis, CEO of Oboro Labs and winner of the Panelists’ Choice award in the established companies category at the spring GatorPitch Miami event.
Oragenics, Inc. Announces Approval To Initiate Phase II Concussion Drug Trial in Australia
UF Innovate | Accelerate graduate Oragenics announced that it has received approval from the Human Research Ethics Committee (HREC) in Australia to initiate a Phase II clinical trial evaluating ONP-002 for the treatment of mild traumatic brain injury (mTBI).
Pheronym®’s Nemastim™ Advances Biological Control of Whiteflies in Breakthrough Foliar Application
UF Innovate | Accelerate alum Pheronym®, an ag-biotech company in sustainable pest management, has announced that pheromones increased beneficial nematodes’ performance against whiteflies in a foliar application.
UF Innovate Awarded Top Entrepreneurship Honors at International Conference
The University of Florida’s start-up incubator, UF Innovate, further solidified its Accelerator program as among the industry’s best after earning top awards at the 2025 International Business Innovation Association’s annual conference in Philadelphia.
Genascence Phase 1b DONATELLO Trial Evaluating Potential First-in-Class Gene Therapy for Knee Osteoarthritis (OA) Meets Primary Endpoint Showing GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation announced positive 12-month safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001, a potential first-in-class gene therapy blocking interleukin 1 (IL-1) for the treatment of knee osteoarthritis (OA).